Imagine a virus so deadly that it wreaks havoc on nearly every part of the body, including the gut, leading to severe diarrhea and life-threatening dehydration. This is the grim reality of Ebola (EBOV) and Marburg (MARV) viruses, which have long puzzled scientists with their ability to cause such devastating symptoms. But here's where it gets even more alarming: a groundbreaking study has revealed that these viruses don’t just pass through the gastrointestinal tract—they actively infect and replicate within human gut cells, disrupting their ability to function properly. This discovery could change how we approach treatment for these deadly diseases.
The research, led by Elizabeth Yvonne Flores, PhD, a recent graduate from Boston University’s Chobanian & Avedisian School of Medicine, sheds new light on the mechanisms behind the gut damage caused by EBOV and MARV. Using advanced lab techniques, the team found that both viruses can infiltrate human gut epithelial cells, interfering with their fluid regulation processes. This mirrors the severe dehydration and diarrhea seen in patients, offering a critical clue to understanding these symptoms.
And this is the part most people miss: the study utilized organoids—tiny, lab-grown structures that mimic human intestinal and colonic tissue. These organoids, derived from induced pluripotent stem cells (iPSCs), allowed researchers to study the viruses in a controlled, human-relevant environment. When infected with EBOV and MARV, these “mini-guts” revealed that the colon is more severely affected than the small intestine, highlighting differences in how these tissues respond to infection.
The viruses were found to disrupt key signaling pathways responsible for ion and fluid transport in the gut, damaging the intestinal lining’s structure. This includes the apical (outermost cell surface) and junctional (cell-to-cell connection) components, which are crucial for controlling what passes through the gut wall. These disruptions likely contribute to the massive fluid loss that leads to fatal diarrhea. Additionally, the infected organoids showed a delayed innate immune response, particularly in the production of interferon-stimulated genes, which are essential for fighting viral infections.
Here’s the controversial part: While this research opens doors to potential targeted treatments, it also raises questions about why these viruses have such a profound impact on the gut compared to other tissues. Could there be unique vulnerabilities in gut cells that make them more susceptible? Or is it the viruses’ ability to evade the immune response in this specific tissue? These questions invite further debate and exploration.
“This organoid platform is a game-changer for studying viral diseases,” explains co-corresponding author Gustavo Mostoslavsky, MD, PhD. “It not only captures the key features of human gastrointestinal pathology but also provides a powerful tool for identifying therapeutic targets.”
As we grapple with the implications of this study, one thing is clear: understanding how EBOV and MARV damage the gut is a critical step toward developing effective treatments. But what do you think? Does this research make you more hopeful about combating these viruses, or does it highlight just how much we still have to learn? Share your thoughts in the comments below.
Reference: Flores EY, Hume AJ, Olejnik J, et al. Filovirus infection disrupts epithelial barrier function and ion transport in human iPSC-derived gut organoids. PLOS Pathogens. 2025;21(11):e1013698. doi:10.1371/journal.ppat.1013698 (https://doi.org/10.1371/journal.ppat.1013698)
This article has been republished and edited for clarity and length. For further information, please contact the cited source. Our press release publishing policy can be accessed here: https://www.technologynetworks.com/tn/editorial-policies#republishing.
